Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical cord serum eye drops for corneal epithelial repair after Trans-PRK
IRCT20250105064285N1Phase 2Completed
- Sponsor
- Baqiyatallah University of Medical Sciences
- Start
- Apr 2025
- Modality
- Stem Cell Therapies → Cell Therapies, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of human umbilical cord blood serum in Corneal epithelial defect (2 arms), sponsored by Baqiyatallah University of Medical Sciences. Primary endpoints: Improvement in corneal epithelial defects and Pain. Started Apr 2025; status: completed.
02
Drugs
human umbilical cord blood serum
03
Conditions
Corneal epithelial defect
Beyond the preview
Go deeper on IRCT20250105064285N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250105064285N1.